Last reviewed · How we verify
CN-Avastin®
At a glance
| Generic name | CN-Avastin® |
|---|---|
| Sponsor | Shanghai Henlius Biotech |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CN-Avastin® CI brief — competitive landscape report
- CN-Avastin® updates RSS · CI watch RSS
- Shanghai Henlius Biotech portfolio CI